CD4+ T Cells Mediate Murine Syngeneic Graft-versus-Host Disease-Associated Colitis

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 679-687

  Bryson, J Scott ^a,c   Zhang, Lining ^a,b   Goes, Sarah W ^a   Jennings, C Darrell ^a   Caywood, Betty E ^a   Carlson, Sonia L ^a   Kaplan, Alan M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOSPORIN A;

ADOPTIVE TRANSFER; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL POPULATION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; ISOGRAFT; MACROPHAGE ACTIVATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 0346103712     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.679     Document Type: Article

References (54)

1. Cheney, R. T., and J. Sprent. 1985. Capacity of cyclosporine to induce autograft-versus-host disease and impair intrathymic T cell differentiation. Transplant. Proc. 17:528.
2. Bryson, J. S., C. D. Jennings, B. E. Caywood, and A. M. Kaplan. 1989. Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation 48:1042.
3. Bryson, J. S., C. D. Jennings, B. E. Caywood, and A. M. Kaplan. 1991. Strain specificity in the induction of syngeneic graft-versus-host disease in mice. Transplantation 51:911.
4. + bone marrow cells regulate the induction of murine syngeneic graft-versus-host disease. Transplantation 56:941.
5. Bucy, R. P., X. Y. Xu, J. Li, and G. Huang. 1993. Cyclosporin A-induced autoimmune disease in mice. J. Immunol. 151:1039.
6. Sorokin, R., H. Kimura, K. Schroder. D. H. Wilson, and D. B. Wilson. 1986. Cyclosporine-induced autoimmunity: conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J. Exp. Med. 164:1615.
7. Bos, G. M. J., G. D. Majoor, and P. J. C. Van Breda Vriesman. 1988. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats. Clin. Exp. Immunol. 74:443.
8. Hess, A. D., L. Horwitz, W. E. Beschorner, and G. W. Santos. 1985. Development of graft-versus-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-la specificity, including autoreactivity. J. Exp. Med. 161:718.
9. Hess, A. D., E. C. Bright. C. Thoburn, G. B. Vogelsang. R. J. Jones, and M. J. Kennedy. 1997. Specificity of effector T lymphocytes in autologous graftversus-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood 89:2203.
10. Fischer, A. C., P. P. Ruvolo, R. Burt, L. R. Horwitz, E. C. Bright, J. M. Hess, W. E. Beschomer, and A. D. Hess. 1995. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease: a highly conserved repertoire mediates autoaggression. J. Immunol. 154:3713.
11. Jenkins, M., R. Schwartz, and D. Pardoll. 1988. Effects of cyclosporine A on T cell development and clonal deletion. Science 241:1655.
12. Gao, E., K. Lo, R. Cheney, O. Kanagawa, and J. Sprent. 1988. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 336:176.
13. Bryson, J. S., B. E. Caywood, and A. M. Kaplan. 1991. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease. J. Immunol. 147:391.
14. Chow, L. H., L. Mosbach-Ozmen, B. Ryffel, and J. F. Borel. 1988. Syngeneic graft-versus-host disease induced by cyclosporine: a reappraisal. Transplantation 46:107S.
15. Bryson, J. S., H. Lake-Bullock, D. L. Pflugh, C. D. Jennings, P. M. Stuart, B. E. Caywood, and A. M. Kaplan. 1995. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-versus-host disease. Transplantation 60:171.
16. Flanagan, D. L., C. D. Jennings, and J. S. Bryson. 1999. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease. J. Immunol. 163:1170.
17. Korngold, R., and J. Sprent. 1987. T cell subsets and graft-versus-host disease. Transplantation 44:335.
18. Ferrara, J. L., F. J. Guillen, P. J. van Dijken, A. Marion, G. F. Murphy, and S. J. Burakoff. 1989. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation 47:50.
19. Kosugi, A., and G. Shearer. 1991. Effect of cyclosporine A on lymphopoiesis. III. Augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporin A. J. Immunol. 146:1416.
20. Flanagan, D. L., R. Gross, C. D. Jennings, B. E. Caywood, S. Goes, A. M. Kaplan, and J. S. Bryson. 2001. Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice. J. Leukocyte Biol. 70:873.
21. Flanagan, D. M., C. D. Jennings, S. W. Goes, B. E. Caywood, R. Gross, A. M. Kaplan, and J. S. Bryson. 2002. Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease. J. Leukocyte Biol. 72:762.
22. Mombaerts, P., E. Mizoguchi, M. Grugsby, L. Glimcher, A. Bhan, and S. Tonegawa 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:275.
23. Sadlack, B., H. Merz, H. Schorle, A. Schimpi, A. Fleller, and I. Gorak. 1993. Ulcerative colitis-like disease in mice with a disruptive interleukin-2 gene. Cell 75:253.
24. Kuhn, R., J. Lohler, D. Rennick, K. Rajewski. and W. Muller. 1993. IL-10 deficient mice develop chronic enteritis. Cell 75:263.
25. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1461.
26. + T cells. J. Exp. Med. 178:237.
27. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J. Immunol. 162:3702.
28. Neurath, M. F., I. Fuss, B. Kelsall, K. H. Meyer zum Buschenfelde, and W. Strober. 1996. Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice. Ann. NY Acad. Sci. 795:368.
29. Neurath, M., I. Fuss, and W. Strober. 2000. TNBS-colitis. Int. Rev. Immunol. 19:51.
30. Sundberg, J. P., C. O. Elson, H. Bedigian, and E. H. Birkenmeier. 1994. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 107:1726.
31. Lefrancois, L., and N. Lycke. 1997. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, Hoboken, NJ, p. 3.19.1.
32. Bryson, J. S., C. D. Jennings, D. M. Lowery, S. L. Carlson, D. L. Pflugh, B. E. Caywood, and A. M. Kaplan. 1999. Rejection of an MHC class 11 negative tumor following induction of murine syngeneic graft-versus-host disease. Bone Marrow Transplant. 23:363.
33. Matsuda, J. L., L. Gapin, B. C. Sydora, F. Byrne, S. Binder, M. Kronenberg, and R. Aranda. 2000. Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis. J. Immunol. 164:2797.
34. Glazier, A., P. J. Tutschka, E. R. Farmer, and G. W. Santos. 1983. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J. Exp. Med. 158:1.
35. Fischer, A. C., W. E. Beschorner, and A. D. Hess. 1989. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease. J. Exp. Med. 169:1031.
36. Chen, W., C. Thoburn, and A. D. Hess. 1998. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease. J. Immunol. 161:7040.
37. Hess, A. D., C. Thobum, and L. Horwitz. 1998. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells. Transplantation 65:785.
38. Hess, A. D., C. J. Thobum, W. Chen, and L. R. Horwitz. 2000. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease. Biol. Blood Marrow Transplant. 6:13.
39. Hess, A. D., C. Thobum, W. Chen, Y. Miura, and E. Van der Wall. 2001. The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen. Clin. Immunol. 101:67.
40. Wu, D. Y., and I. Goldschneider. 1999. Cyclosporin A-induced-autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants. J. Immunol. 162:6926.
41. Hess, A. D., and C. J. Thoburn. 1997. Immunobiology and imnmnotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol Rev. 157:111.
42. Beschomer, W., C. Shinn, A. Fischer, G. Santos, and A. Hess. 1988. Cyclosporine-induced graft-versus-host disease in the early post-cyclosporine period. Transplantation 46:112S.
43. + T lymphocyte subsets. J. Immunol. 145:526.
44. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. ImmunoL 20:495.
45. Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murphy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6:157.
46. Myers, K. J., M. J. Eppihimer, L. Hall, and B. Wolitzky. 1998. Interleukin-12-induced adhesion molecule expression in murine liver. Am. J. Pathol. 152:457.
47. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154:4333.
48. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187:855.
49. + T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J. Immunol. 165:2173.
50. Liu, L. M., and G. G. MacPherson. 1993. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177:1299.
51. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
52. Hess, A. D., and E. C. Bright. 1991. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine. Transplantation 51:1232.
53. Van Gool, S. W., M. de Boer, and J. L. Ceuppens. 1993. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J. Immunol. 150:3254.
54. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548.